We observe a substantial increase in GDM risk with elevated glypican-4 levels, particularly when glypican-4 levels exceeding 0.40 ng/mL in the first trimester (5-12 weeks of gestation) or 0.79 ng/mL in the second trimester (13-23 weeks of gestation). The gene discussed is GPC4; the disease is gestational diabetes.